VertiFlex®, Inc. Announces Financing and New Investment Partner (press release)
VertiFlex, a leading innovator of percutaneous and motion preserving spinal surgery technologies, today announced completion of a $14M equity placement, with provision for an additional $14M investment within twelve months.
The new capital will be used to complete enrollment in the Superion® Interspinous Spacer (ISS) IDE Trial before the end of 2011, and to advance global market development of the technology